lansoprazole has been researched along with chlorine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eiro, M; Katoh, T; Watanabe, T | 1 |
| Levin, M; Mercola, M; Nogi, T; Robinson, KR; Thorlin, T | 1 |
| Kashif, M; Rahman, N | 1 |
| Girish, RK; Mishra, PK; Nagappa, AN; Pandi, PV; Shanmukh, I | 1 |
4 other study(ies) available for lansoprazole and chlorine
| Article | Year |
|---|---|
Use of a proton-pump inhibitor for metabolic disturbances associated with anorexia nervosa.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Alkalosis; Anorexia Nervosa; Bicarbonates; Bulimia; Chlorides; Female; Humans; Hypokalemia; Lansoprazole; Omeprazole; Proton Pump Inhibitors | 2002 |
Asymmetries in H+/K+-ATPase and cell membrane potentials comprise a very early step in left-right patterning.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Barium Compounds; Body Patterning; Cell Membrane; Chick Embryo; Chlorides; Electrophysiology; Enzyme Inhibitors; H(+)-K(+)-Exchanging ATPase; In Situ Hybridization; Lansoprazole; Membrane Potentials; Molecular Sequence Data; Omeprazole; Potassium Channels, Inwardly Rectifying; Proton Pump Inhibitors; RNA, Messenger; Time Factors; Xenopus | 2002 |
Hypothesis testing for the validation of the kinetic spectrophotometric methods for the determination of lansoprazole in bulk and drug formulations via Fe(III) and Zn(II) chelates.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Calibration; Chlorides; Data Interpretation, Statistical; Ferric Compounds; Iron Chelating Agents; Kinetics; Lansoprazole; Pharmaceutical Preparations; Spectrophotometry; Zinc; Zinc Compounds | 2010 |
Transport through liquid membranes containing omeprazole and lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Bicarbonates; Biochemistry; Cations; Chemistry, Pharmaceutical; Chlorides; Cholesterol; Drug Design; Enzyme Inhibitors; Hydrogen-Ion Concentration; Ions; Lansoprazole; Lecithins; Membranes, Artificial; Models, Biological; Models, Chemical; Molecular Conformation; Omeprazole; Permeability | 2002 |